NCT04251689View on ClinicalTrials.gov

The Effect of Intravenous Mannitol Plus Saline on the Prevention of Cisplatin-induced Nephrotoxicity: A Randomized, Double-blind, Placebo Controlled Trial

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

July 1, 2020

Study Completion Date

February 14, 2021

Conditions
Cis-Platinum NephropathyMannitol Adverse Reaction
Interventions
DRUG

Mannitol

Mannitol 20 gram plus 0.9% normal saline 100 ml one hour after cisplatin

DRUG

Placebo

0.9% normal saline 100 ml

Trial Locations (1)

10400

Phramongkutklao Hospital, Bangkok

All Listed Sponsors
lead

Phramongkutklao College of Medicine and Hospital

OTHER

NCT04251689 - The Effect of Intravenous Mannitol Plus Saline on the Prevention of Cisplatin-induced Nephrotoxicity: A Randomized, Double-blind, Placebo Controlled Trial | Biotech Hunter | Biotech Hunter